PDCD1 and neoplasm: Specifically, several studies have explored PD-L1 expression in tumor cells from patients treated with PD-1/PD-L1 axis inhibitors, and significant antitumor activity has been shown in patients with PD-L1-positive tumors, although responses have also been observed in PD-L1-negative patients5-.10